Meet Vrio’s Big, Bold IPO
AT&T spin-off Vrio expects to price more than 29 million shares in a range that results in an initial public offering valued up to about $751 million.
All Work
Chris Lange
LinkedIn Sees Even More Job Growth in March
This LinkedIn report comes out on a monthly basis and highlights who is hiring in the United States and where jobs are growing the quickest.
Conatus Pharmaceuticals Stumbles on Midstage Miss
Conatus Pharmaceuticals shares took a big step back on Thursday after the firm announced that its midstage proof-of-concept clinical trial in liver transplant patients with fibrosis or cirrhosis failed to live up to expectations.
Is Conn’s in Trouble After Q4 Earnings?
Conn’s released mixed fiscal fourth-quarter financial results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday ended up being a positive day for the broad U.S. markets. The major indices started the day out incredibly negative and over the course of the day worked their way up to a…
Should Major Video Game Publishers Be Worried About Fortnite?
Fortnite is taking the world by storm. And this could spell some problems for major video game publishers.
Are Analysts Calling Tesla Investors Nearsighted?
Tesla said in its first-quarter update that it "does not require an equity or debt raise this year," although this has analysts somewhat skeptical.
More Trouble Keeps Brewing at Dave & Buster’s
After Dave & Buster’s released its most recent quarterly results, the stock hit a new 52-week low.
Why Good Earnings Can’t Save Cloudera
When Cloudera reported its fiscal fourth-quarter financial results, it looked like a strong quarter with solid beats on both the top and bottom lines.
Proteostasis Therapeutics Wins Big With FDA Decision
Proteostasis Therapeutics shares made a solid gain on Wednesday after a key FDA decision was announced.
Why CarMax Earnings Crashed
CarMax released disappointing fourth-quarter financial results before the markets opened on Wednesday.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets, a slight recovery from Monday’s dramatic session. Everything seemed to perk up a little, even oil made a small recovery as well. And even…
Spotify Explodes in Market Debut
Spotify stock has absolutely exploded in the market, confirming practically all the bullish analysts ahead of the offering.
YogaWorks Gets Bent Out of Shape With Q4 Earnings
YogaWorks released its most recent quarterly results after the markets closed on Monday and shares tumbled on Tuesday.
American Craft Beers Cheer Rising International Sales
The Brewers Association (BA), a not-for-profit trade group representing small independent craft brewers, released a study showing how American craft beer is rising to prominence on the international scene.
SEC Cracks Down on Crypto Fraud
Jamie Dimon and others have called bitcoin and cryptocurrencies in general fraudulent. And now it seems the SEC is proving them right.
Celgene Shuffles the Deck: COO Steps Down Immediately
Celgene is shuffling the deck in terms of its executive leadership, and one of its top executives is stepping down.
Rigel Pharmaceuticals Stumbles on Midstage Kidney Trial
Rigel Pharmaceuticals saw its shares pull back early on Tuesday after the firm announced topline data from a midstage study.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the broad U.S. markets, with each index posting a loss of at least 1.9%. With Monday’s lower close that marks the eleventh time out of the past 15…
Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage
Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems to be the product of overall market sentiment as opposed to these results.